Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mechanisms of Resistance

Reduced Antimony Accumulation in ARM58-Overexpressing Leishmania infantum

Carola Schäfer, Paloma Tejera Nevado, Dorothea Zander, Joachim Clos
Carola Schäfer
Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paloma Tejera Nevado
Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dorothea Zander
Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joachim Clos
Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.01881-13
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • FIG 1
    • Open in new tab
    • Download powerpoint
    FIG 1

    Validation of LinARM58. (A) Putative domain structure of LinARM58 and LinARM58rel. The boxes represent 4 putative domains of unknown function (DUF1935) for each protein. TMD, transmembrane domain; insertion, 31-amino-acid sequence absent from ARM58rel. The numbers below the structures show the positions within the amino acid sequence. (B) Dose-inhibition experiment for growth of L. infantum carrying the indicated transgenes at the indicated antimonyl tartrate (SbIII) concentrations. Growth over 72 h was normalized to that of the 0 μM samples (100%). The dotted lines indicate the respective IC50s. **, P < 0.01; ***, P < 0.001 (n = 8). (C) As for panel B, but with L. donovani 1SR as the acceptor strain. (D) In vitro infection of bone marrow-derived macrophages and treatment with sodium stibogluconate. L. infantum transfected with vector or with the ARM58 transgene was used to infect BMMs at a 10:1 ratio. After 4 h, extracellular parasites were removed. Sodium stibogluconate was added to the cultures at 160 μg/ml, and incubation was continued for 72 h. After DAPI staining, infection rates relative to the untreated control infections (data not shown) were determined by fluorescence microscopy (10 experiments with 100 macrophages each). The horizontal bars depict the median values. **, P < 0.01. (E) As for panel D, except that L. donovani 1SR served as the acceptor strain. *, P < 0.05 (n = 6). (F) As for panel B, except that parasites were treated with the indicated concentrations of miltefosine. (G) As for panel B, except that parasites were treated with the indicated concentrations of pentamidine.

  • FIG 2
    • Open in new tab
    • Download powerpoint
    FIG 2

    (A) Schematic depiction of ARM58 deletion constructs used for panels B and C. The shaded boxes represent the four DUF1935 putative domains. The black box signifies the putative transmembrane domain (TMD). The numbers indicate the positions relative to the wild-type amino acid sequence; insertion, 31-amino-acid sequence absent from ARM58rel. (B) SbIII IC50s (μM) for L. infantum carrying the indicated ARM58 variants. *, P < 0.05 (n = 4) relative to full-length ARM58. (C) As for panel B, but with further shortened ARM58 variants (n = 4).

  • FIG 3
    • Open in new tab
    • Download powerpoint
    FIG 3

    (A) Schematic depiction of mutated ARM58 constructs used for panel B. The shaded boxes represent the 4 DUF1935 putative domains. The black box signifies the putative transmembrane domain (TMD). The numbers indicate the positions relative to the wild-type amino acid sequence. (B) SbIII IC50s (μM) for L. infantum carrying the indicated ARM58 mutants. *, P < 0.05 (n = 4) relative to full-length ARM58. (C) Schematic depiction of ARM58rel, ARM58, and two DUF1935-III domain swapping mutants, ARM58_3Drel and ARM58rel_D3. (D) As for panel B, but testing domain swapping mutants of ARM58 and AMR58rel (n = 4).

  • FIG 4
    • Open in new tab
    • Download powerpoint
    FIG 4

    Subcellular localization of mCH::ARM58 fusion proteins. (A) Schematic depiction of the episomal expression plasmid pCL2N-mCH::ARM58. (B) Functional test of mCherry::ARM58 fusion protein. L. infantum overexpressing either ARM58 (solid squares) or mCH::ARM58 (diamonds) was subjected to a 72-h dose effect growth experiment with various SbIII concentrations and compared to a control strain transfected with pCLN (vector). Dotted lines show IC50s; error bars show standard deviations (n = 4). (C to F) Fluorescence microscopy imaging of L. infantum(pCL2N-mCH::ARM58) showing differential inference contrast (DIC) (C), DAPI (D), and mCherry (E) channels plus overlay of DAPI and mCherry (F). n, nucleus; k, kinetoplast. (G to K) Confocal laser microscopy imaging of L. infantum(pCL2N-mCH::ARM58) showing DIC (G), DAPI (H), and mCherry (I) channels plus overlay of DAPI and mCherry (K). n, nucleus; k, kinetoplast. Size bar, 5 μm.

  • FIG 5
    • Open in new tab
    • Download powerpoint
    FIG 5

    Intracellular Sb concentration following SbIII exposure. L. infantum(pCLN) and L. infantum(pCLN-ARM58) were incubated for 48 h with 0 μM or at 400 μM SbIII. Cells were then counted (A). From each culture, 5 × 107 promastigotes were precipitated, washed, and lysed in nitric acid. Sb concentration in each lysate was measured by inductively coupled plasma mass spectrometry (ICPMS) (n = 3) (B). (C and D) Induction of SbIII resistance in strains receiving 10 μM verapamil (C) or 50 μM sodium vanadate (D). Vector controls and ARM58 overexpressing L. infantum were grown for 72 h. Cell densities were measured and plotted against the indicated SbIII concentrations. Values are the medians from 4 independent experiments. V, verapamil; SV, sodium vanadate.

PreviousNext
Back to top
Download PDF
Citation Tools
Reduced Antimony Accumulation in ARM58-Overexpressing Leishmania infantum
Carola Schäfer, Paloma Tejera Nevado, Dorothea Zander, Joachim Clos
Antimicrobial Agents and Chemotherapy Feb 2014, 58 (3) 1565-1574; DOI: 10.1128/AAC.01881-13

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Reduced Antimony Accumulation in ARM58-Overexpressing Leishmania infantum
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Reduced Antimony Accumulation in ARM58-Overexpressing Leishmania infantum
Carola Schäfer, Paloma Tejera Nevado, Dorothea Zander, Joachim Clos
Antimicrobial Agents and Chemotherapy Feb 2014, 58 (3) 1565-1574; DOI: 10.1128/AAC.01881-13
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596